Pacira BioSciences

PCRX

Market cap $901M

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$32

49% upside

High target

positive

1 neutral

33%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
HC Wainwright & Co Douglas Tsao 50% 1-yr PCRX win rate				9 Jan ‘26 1 month ago
Needham Serge Belanger 67% 1-yr PCRX win rate				9 Jan ‘26 1 month ago
Barclays Glen Santangelo				9 Dec ‘25 2 months ago